Samsung Biologics Reports First Quarter 2026 Financial Results

Recorded Q1'26 revenue of KRW 1,257 billion and operating profit of KRW 581 billion Performance driven by full utilization across Plants 1 through 4 and robust operational execution Strengthened the foundations for future growth through U.S. expansion and strategic partnerships INCHEON,...